German Science & Technology Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on German Science & Technology Today.

Press releases published on November 3, 2026

Nov. 3, 2026

Goldcote Launches Four Free Travel Finders for Direct Trains, Buses, Hotels and Whole Trips

Indeterminate EIN Presswire

Nov. 3, 2026

Haptic Patch Improves Leg Strength and Symmetry in Elite Athletes

Indeterminate EIN Presswire

Nov. 3, 2026

HERO CNC investiert in Ultrapräzision: Neue Maßstäbe bei Toleranzen unter 5mu

Indeterminate EIN Presswire

Nov. 3, 2026

PPST Solutions Expands AI Data Center Power Testing Portfolio from AC Grid to 800 VDC

Indeterminate EIN Presswire

Nov. 3, 2026

Costa Rica's Medical Cannabis Market Advances in Exports and Manufacturing as Patients Await Pharmacy Access

Indeterminate EIN Presswire

Nov. 3, 2026

Innovatrics Achieves High-Level Injection Attack Detection Certification for European Identity Proofing

Indeterminate EIN Presswire

Nov. 3, 2026

Devart Updates Its Entire Delphi Line for RAD Studio 13 Florence Release 2, SQL Server 2025 and MySQL 9.7

Indeterminate EIN Presswire

Nov. 3, 2026

IAMTech and Alert Disaster Control launch Avertis Intelligence to strengthen emergency preparedness at industrial sites

Indeterminate EIN Presswire

Nov. 3, 2026

trivago Delivers 16% Growth in Q3, Its Seventh Consecutive Double-Digit Quarter, With Highest Adjusted EBITDA Since Mid-2023

Indeterminate GlobeNewswire

Nov. 3, 2026

Oryzon announces authorization in Spain of VIVALDI, a collaborative clinical study with CETLAM to evaluate iadademstat in combination with standard-of-care therapy in high-risk newly-diagnosed AML subpopulations

Indeterminate GlobeNewswire

Nov. 3, 2026

BioNTech veröffentlicht Ergebnisse für das dritte Quartal 2026 sowie Informationen zur Geschäftsentwicklung

Indeterminate GlobeNewswire

Nov. 3, 2026

BioNTech Announces Third Quarter 2026 Financial Results and Corporate Update

Indeterminate GlobeNewswire

Nov. 3, 2026

Starke Verkaufszahlen für Cresemba® (Isavuconazol) in Europa lösen USD 37.5 Mio. Meilensteinzahlung an Basilea aus

Indeterminate GlobeNewswire

Nov. 3, 2026

Strong Cresemba® (isavuconazole) sales in Europe trigger USD 37.5 million milestone payment to Basilea

Indeterminate GlobeNewswire